Fig. 7

A Immune cell infiltration landscape map under ARI classification in the TCGA cohort. B Differences in immune-related pathways between ARI high-risk group and low-risk group. C Gene expression differences in HLA-associated gene sets within two apparently distinct ARI risk groups. D Waterfall plot of tumor somatic mutations in the ARI high-risk group. E Waterfall plot of tumor somatic mutations in the ARI low-risk group. F Comparison of tumor mutation burden between high and low risk groups. G Correlation between mutation burden and ARI score in TCGA database. H Expression of immune checkpoint molecules in ARI high- and low-risk groups. I Differential PD-L1 expression in ARI high- and low-risk groups. J Survival analysis in high and low tumor mutational burden in the TCGA database. K Survival analysis in TCGA database stratified by high and low tumor mutation burden combined with ARI high risk group. L–U Correlation analysis of ips, dysfunction, exclusion, IFNG, MDSC, MSI and TAM.M2 in ARI high and low risk groups in TCGA database